From bench to bedside:
Clinical translation
Copper-64
Dose extrapolation
Dosimetry
Fusion protein antibody
Lutetium-177
PET imaging
Radioimmunotherapy
Theranostic
Tumor endothelial marker 1
Journal
EJNMMI research
ISSN: 2191-219X
Titre abrégé: EJNMMI Res
Pays: Germany
ID NLM: 101560946
Informations de publication
Date de publication:
14 Jun 2023
14 Jun 2023
Historique:
received:
24
04
2023
accepted:
06
06
2023
medline:
14
6
2023
pubmed:
14
6
2023
entrez:
14
6
2023
Statut:
epublish
Résumé
The development of diagnostic and therapeutic radiopharmaceuticals is an hot topic in nuclear medicine. Several radiolabeled antibodies are under development necessitating both biokinetic and dosimetry extrapolations for effective human translation. The validation of different animal-to-human dosimetry extrapolation methods still is an open issue. This study reports the mice-to-human dosimetry extrapolation of
Identifiants
pubmed: 37314509
doi: 10.1186/s13550-023-01010-4
pii: 10.1186/s13550-023-01010-4
pmc: PMC10267050
doi:
Types de publication
Journal Article
Langues
eng
Pagination
59Subventions
Organisme : Agence Nationale de la Recherche
ID : IRON LabEx n° ANR-11-LABX-0018-01
Organisme : Agence Nationale de la Recherche
ID : IGO LabEx n° ANR-11-LABX-0016-01
Organisme : Agence Nationale de la Recherche
ID : n° ANR-11-EQPX-0004
Organisme : Agence Nationale de la Recherche
ID : n° ANR-16-IDEX-0007
Informations de copyright
© 2023. The Author(s).
Références
EJNMMI Res. 2020 Aug 17;10(1):98
pubmed: 32804276
Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1442-57
pubmed: 20934273
Clin Exp Metastasis. 2004;21(1):31-7
pubmed: 15065600
Q J Nucl Med Mol Imaging. 2019 Jun;63(2):191-198
pubmed: 27171605
Sci Rep. 2019 Sep 6;9(1):12815
pubmed: 31492910
Cancer Biother Radiopharm. 2005 Apr;20(2):195-9
pubmed: 15869455
EJNMMI Phys. 2016 Dec;3(1):25
pubmed: 27770429
Eur J Nucl Med Mol Imaging. 2021 May;48(5):1570-1584
pubmed: 33433699
Int J Radiat Oncol Biol Phys. 1991 May 15;21(1):109-22
pubmed: 2032882
N Engl J Med. 1993 Oct 21;329(17):1219-24
pubmed: 7692295
Cancer Res. 2020 Feb 15;80(4):868-876
pubmed: 31772036
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2021 Mar;165(1):99-101
pubmed: 32975243
Mol Imaging Biol. 2020 Aug;22(4):979-991
pubmed: 31993928
Eur J Nucl Med Mol Imaging. 2022 May;49(6):1778-1809
pubmed: 35284969
Oncotarget. 2019 Jan 29;10(9):993-1009
pubmed: 30847027
Contrast Media Mol Imaging. 2019 Jan 3;2019:6438196
pubmed: 30733648
Ann ICRP. 2007;37(2-4):1-332
pubmed: 18082557
Neoplasma. 2016;63(2):183-92
pubmed: 26774137
Clin Oncol (R Coll Radiol). 2021 Feb;33(2):92-97
pubmed: 33189510
J Nucl Med. 2010 Dec;51(12):1878-84
pubmed: 21098795
Cancers (Basel). 2021 Nov 25;13(23):
pubmed: 34885044
Clin Cancer Res. 2005 Jul 15;11(14):5215-22
pubmed: 16033839
Eur J Nucl Med Mol Imaging. 2008 Jul;35(7):1405-12
pubmed: 18491092
Ann ICRP. 2002;32(3-4):5-265
pubmed: 14506981
Eur J Cancer. 2018 Feb;90:111-121
pubmed: 29304474
J Nucl Med. 2003 Dec;44(12):2000-18
pubmed: 14660727
Microvasc Res. 2008 Nov;76(3):180-8
pubmed: 18761022
Oncotarget. 2014 Jun 30;5(12):3983-95
pubmed: 24980818
J Nucl Med. 2021 Dec;62(Suppl 3):23S-35S
pubmed: 34857619
Nat Rev Drug Discov. 2020 Sep;19(9):589-608
pubmed: 32728208
J Nucl Med. 2009 Nov;50(11):1828-36
pubmed: 19837762
Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2426-2441
pubmed: 29785514
EJNMMI Radiopharm Chem. 2022 Jul 19;7(1):18
pubmed: 35852679
Gene Expr Patterns. 2007 Jan;7(3):363-9
pubmed: 16965941
Ann Surg Oncol. 2010 Jun;17(6):1471-4
pubmed: 20180029
J Nucl Med. 2018 Jan;59(1):154-160
pubmed: 28887400
Ann Surg. 1982 Sep;196(3):305-15
pubmed: 7114936
J Nucl Med. 2014 Jan;55(1):23-9
pubmed: 24337604
Br J Cancer. 2016 Aug 9;115(4):473-9
pubmed: 27434038
Curr Drug Targets. 2012 Mar;13(3):432-9
pubmed: 22206249
EJNMMI Res. 2022 Apr 11;12(1):21
pubmed: 35403982
J Nucl Med. 2003 Mar;44(3):451-6
pubmed: 12621014
Pharmaceutics. 2021 Jan 13;13(1):
pubmed: 33451158
Lancet Oncol. 2020 Mar;21(3):e146-e156
pubmed: 32135118
Am J Roentgenol Radium Ther Nucl Med. 1962 Jan;87:171-82
pubmed: 13867399